These oral versions of GLP-1 drugs are offered at a fraction of the cost of the injectable originals, leading to a surge in online sales despite safety and efficacy concerns.
Platforms like Instagram and Facebook are rife with ads for these compounded medications, which are increasingly becoming popular among those who dislike needles, despite their questionable effectiveness.
The rise of these compounding pharmacies coincided with the shortage of injectable GLP-1 drugs that began in 2022, allowing these businesses to flourish under legal loopholes.
While some patients find the convenience of oral GLP-1 options appealing, experts caution that the lack of regulation and scientific backing raises serious concerns about their reliability.
Collection
[
|
...
]